A new tool for diagnosing diabetic retinopathy using advanced imaging and artificial intelligence.
A diagnostic platform for diabetic retinopathy based on OCT angiography and artificial intelligence
This study is working on a new tool that uses advanced imaging and smart technology to help doctors better and more easily diagnose and understand diabetic retinopathy, a common eye condition that affects many people with diabetes.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ifocus Imaging LLC NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11011245 on NIH RePORTER |
What this research studies
This research focuses on developing a diagnostic platform that utilizes optical coherence tomography angiography (OCTA) combined with artificial intelligence to improve the diagnosis and staging of diabetic retinopathy (DR). The approach aims to automate the grading of OCTA images, making it easier and more reliable for healthcare providers to assess the severity of DR. By enhancing the segmentation of key features in OCTA images, this project seeks to provide a non-invasive and efficient method for diagnosing a condition that affects millions worldwide.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with diabetic retinopathy or those at risk of developing the condition.
Not a fit: Patients without diabetes or those who do not have diabetic retinopathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely diagnoses of diabetic retinopathy, potentially reducing the risk of blindness for patients.
How similar studies have performed: Previous research has shown promise in using AI for medical imaging, indicating that this approach could lead to significant advancements in the diagnosis of diabetic retinopathy.
Where this research is happening
Portland, United States
- Ifocus Imaging LLC — Portland, United States (Active)
Researchers
- Principal investigator: Hormel, Tristan — Ifocus Imaging LLC
- Study coordinator: Hormel, Tristan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.